Pycnogenol Shows Promise in ADHD Trials, More Research Needed
Pycnogenol, an extract from Maritime Pine Bark, is gaining attention in the ADHD community for potential benefits. Several small trials show promising results in reducing hyperactivity and improving attention in children with ADHD. However, more research is needed to confirm these findings.
Pycnogenol, also known as Maritime Pine Bark extract, has been examined in several small randomized controlled trials for treating ADHD in children. These studies suggest improvements in hyperactivity, attention, and oxidative stress markers. However, the evidence is not yet conclusive due to methodological limitations and small sample sizes.
Research on Maritime Pine Bark extract has primarily focused on its antioxidant properties and potential benefits in cardiovascular diseases and certain cognitive impairments in children, rather than ADHD specifically. No specific researchers or institutions are mentioned in the search results for ADHD studies. Clinicians sometimes recommend Pycnogenol as a complementary approach for managing ADHD symptoms, with some children showing improvements in hyperactivity and impulsivity.
A 2006 study involving 61 children with ADHD found significant improvements in hyperactivity and attention after one month of Pycnogenol supplementation. However, these benefits seemed to fade once supplementation stopped. The extract contains antioxidant compounds called procyanidins, which may improve brain blood flow and influence catecholamine balance, the system involved in focus and attention in children with ADHD.
Pycnogenol is generally considered safe, with few reported side effects. However, it may affect blood clotting, so people on anticoagulant medications should consult a healthcare professional before use. Most ADHD studies have used doses of around 1 mg per kilogram of body weight daily for children with ADHD, translating to roughly 30-60 mg. Supplements on the market typically range from 50 to 150 mg per day for adults.
While initial data on Pycnogenol for ADHD in children is encouraging, more large-scale, well-designed trials are needed to confirm its efficacy and safety. Until then, clinicians may recommend it as a complementary approach for managing ADHD symptoms, but expectations should remain measured. Always consult with a healthcare professional before starting any new supplement.
Read also:
- Abu Dhabi initiative for comprehensive genetic screening, aiming to diagnose over 800 conditions and enhance the health of future generations in the UAE.
- Elderly shingles: Recognizing symptoms, potential problems, and available treatments
- Protecting Your Auditory Health: 6 Strategies to Minimize Noise Damage
- Exploring the Reasons, Purposes, and Enigmas of Hiccups: Delving into Their Origins, Roles, and Unsolved Aspects
